James L. Cave - 31 May 2024 Form 4 Insider Report for Teladoc Health, Inc. (TDOC)

Role
INTERIM CAO
Signature
/s/ Adam C. Vandervoort, Attorney-in-Fact
Issuer symbol
TDOC
Transactions as of
31 May 2024
Net transactions value
-$9,528
Form type
4
Filing time
04 Jun 2024, 16:05:37 UTC
Previous filing
06 May 2024
Next filing
04 Sep 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TDOC Common Stock Options Exercise +339 +3.2% 10,787 31 May 2024 Direct F1
transaction TDOC Common Stock Options Exercise +1,001 +9.3% 11,788 31 May 2024 Direct F1
transaction TDOC Common Stock Options Exercise +383 +3.2% 12,171 31 May 2024 Direct F1
transaction TDOC Common Stock Options Exercise +1,162 +9.5% 13,333 31 May 2024 Direct F1
transaction TDOC Common Stock Sale $9,528 -854 -6.4% $11.16 12,479 03 Jun 2024 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TDOC Restricted Stock Units Options Exercise $0 -339 -25% $0.000000 1,017 31 May 2024 Common Stock 339 Direct F1, F3
transaction TDOC Restricted Stock Units Options Exercise $0 -1,001 -100% $0.000000* 0 31 May 2024 Common Stock 1,001 Direct F1, F4
transaction TDOC Restricted Stock Units Options Exercise $0 -383 -20% $0.000000 1,534 31 May 2024 Common Stock 383 Direct F1, F5
transaction TDOC Restricted Stock Units Options Exercise $0 -1,162 -12% $0.000000 8,139 31 May 2024 Common Stock 1,162 Direct F1, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
F2 Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards.
F3 On April 1, 2022, the reporting person was granted 4,067 restricted stock units, vesting one-third on March 1, 2023, with the remainder vesting in eight substantially equal quarterly installments thereafter.
F4 On June 1, 2022, the reporting person was granted 4,002 restricted stock units, vesting in four substantially equal semiannual installments beginning on the six-month anniversary of the grant date.
F5 On June 1, 2022, the reporting person was granted 4,598 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.
F6 On March 3, 2023, the reporting person was granted 13,951 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.